Eterna Therapeutics Inc. (ERNA)

Eterna Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12	10	9	217	7	6
Market Cap Growth	-25.51%	2.51%	-95.63%	3169.98%	4.07%	13.82%
Enterprise Value	50	40	-5	203	8	9
PE Ratio	-	-0.45	-0.38	-1.77	-0.91	-3.09
PS Ratio	101.15	142.82	-	-	-	0.32
PB Ratio	-3.81	4.35	0.78	8.51	0.87	1.25
P/FCF Ratio	-0.71	-0.48	-0.45	-9.18	-0.82	3.87
P/OCF Ratio	-0.72	-0.48	-0.45	-9.24	-0.82	2.32
EV/Sales Ratio	433.69	586.54	-	-	-	0.46
EV/EBITDA Ratio	-2.57	-2.00	0.20	-1.66	-1.10	6.58
EV/EBIT Ratio	-2.38	-1.89	0.20	-1.66	-1.08	-5.19
EV/FCF Ratio	-2.81	-1.95	0.23	-8.58	-0.97	5.57
Debt / Equity Ratio	-13.91	18.74	0.10	0.11	0.38	1.19
Debt / EBITDA Ratio	-2.38	-2.10	-0.05	-0.02	-0.40	4.35
Debt / FCF Ratio	-2.60	-2.05	-0.06	-0.12	-0.36	3.68
Quick Ratio	1.23	1.84	2.15	4.81	0.52	0.73
Current Ratio	0.79	1.46	1.79	5.10	0.55	1.00
Asset Turnover	0.00	0.00	0	0	0	1.30
Interest Coverage	-15.36	-34.29	-816.80	-	-	-7.11
Return on Equity (ROE)	-1466.80%	-509.00%	-185.60%	-707.40%	-209.30%	-33.30%
Return on Assets (ROA)	-46.30%	-53.10%	-93.30%	-313.60%	-81.50%	-13.50%
Return on Capital (ROIC)	-49.82%	-48.71%	-258.54%	-402.93%	-68.66%	-15.85%
Earnings Yield	-197.00%	-223.28%	-259.62%	-56.47%	-109.86%	-32.35%
FCF Yield	-156.65%	-210.34%	-221.91%	-10.89%	-122.65%	25.87%
Buyback Yield / Dilution	-5.52%	-74.17%	-40.92%	-146.19%	-1123.51%	-6.96%
Total Shareholder Return	-5.52%	-74.17%	-40.92%	-146.19%	-1123.51%	-6.96%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).